Massachusetts Court Reviews Cannabis Policy Initiative
Massachusetts Supreme Judicial Court heard recent arguments regarding a challenge to a ballot measure that may have significant implications on the state’s cannabis-regulated industry. This includes medical cannabis access. This case is, Caroline Pineau, et al. v. Attorney-General and Secretary of the State, SJC 13927This initiative, entitled “An Act to Restore an Sensible Cannabis Policy,” is being considered. The initiative, titled “An Act to Restore a Sensible Marijuana Policy,” is likely to be on the November election ballot if the SJC rejects the challengers.
Legal arguments and the Initiative
The initiative is aimed at repealing Chapters 94G &64N of the General Laws that currently govern the possession, sale, distribution and taxation on marijuana not prescribed for medical purposes. The petition claims that it will “continue to allow the use of marijuana for non-medical purposes”.[e] The medical program” Plaintiffs, industry groups and other stakeholders argue it would have a broader impact on medical cannabis patient access.
Adam Fine of Vicente LLP and Tim Swain are representing the plaintiffs, who are Massachusetts registered voters and grant recipients for cannabis social equity. According to them, the petition is in violation of constitutional standards because it incorporates unrelated policies and contradictory ones. The key point made in oral arguments is that the initiative will eliminate the mandate for social equity, which was designed to promote participation of communities affected disproportionately by prohibitions. It could also mean the end of the Social Equity Trust Fund and policies that support social equity applicants. The plaintiffs have also raised concern about the increase in penalties for simple possession of marijuana.
Massachusetts Cannabis Coalition, the largest industry association in Massachusetts and cannabis state of Massachusetts (MCC), participated as an Amicus Curiae Christine Baily, C Bailey Law LLC (friend of court), as reported by Marijuana Moment. In its brief, the MCC argued that Attorney General’s certification of and summary of petition was based on a version of state laws which is outdated. Voters might not fully understand the implications of a petition. MCC asserted, too, that the petition and its summary did not accurately reflect the impact of the repeal proposal on the medical program or patient access. Massachusetts Cannabis Control Commission, the state’s regulator for adult-use programs and medical marijuana, has traditionally interpreted both programs as being interrelated. This suggests that partial repeal would not be able to separate these programs without wider consequences. MCC also warned against the potential impact of the repeal on individuals who are using cannabis adult-use for therapeutic purposes.
The court’s deliberation, and possible outcomes
In general, it is difficult to successfully challenge the Attorney General’s certification or summary of a voter petition. The SJC justices seemed to be aware of Massachusetts’ constitutional right to pass legislation through the ballot box during Monday’s argument. The SJC will likely make a decision by the end of June.
The litigation, even if it ultimately decides against the plaintiffs to allow the petition to appear on the ballot in November, has highlighted the possible ramifications to the medical cannabis industry. Dominguez stated that MCC was “standing up both for the cannabis industry as well as the will the voters” in a recent statement. He also stressed the need to inform voters about the potential impact of this initiative on the industry. It could dismantle it, recriminalize the possession and reduce patient access. Marijuana Moment. This legal challenge aims to reveal omissions from the summary of the Attorney General and to clarify the implications of repealing certain parts of Massachusetts’ cannabis laws. It is intended to educate Massachusetts voters on what’s at stake for this industry.
Disclaimer: The information contained in this article does not constitute medical advice. Hemp Gazette is not a medical provider and does not offer diagnoses or treatment plans. Consult a healthcare professional before you make any decision regarding your health. Therapeutic Goods Administration of Australia has not evaluated statements about the therapeutic benefits of cannabinoids, hemp or cannabis. TGA regulations allow Australians to access medical cannabis through prescription.